Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 5/2018

01.09.2017 | Original Article

New Evidence to Support Antibiotic Prophylaxis in Meconium-Stained Amniotic Fluid in Low-Risk Women in Labor a Prospective Cohort Study

verfasst von: Kavitha Abraham, Elsy Thomas, Jessie Lionel

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of study

To assess the maternal and perinatal complications associated with meconium-stained amniotic fluid (MSAF) in low-risk women in labor.

Methods

This prospective cohort study was conducted at CMC Hospital, Vellore, India. Two hundred low-risk women who had artificial or spontaneous rupture of membranes after admission with MSAF were included in the study. Two hundred similar women with clear liquor were taken as controls. The primary outcomes considered were the incidence of chorioamnionitis and endomyometritis in the mothers. The secondary outcomes included postpartum hemorrhage and retained placenta in the mothers and respiratory distress, meconium aspiration, sepsis, and NICU admission in the newborn. Statistical analysis was done using Fischer exact test. Odds ratio, 95% confidence interval, and P value were estimated.

Results

Compared to controls, those with MSAF had significantly higher rates of chorioamnionitis (2 vs. 8%, P = 0.006) and endomyometritis (3 vs. 9.5% P = 0.007). Among the secondary end points, only neonatal respiratory distress (8.5 vs. 1.5%; P = 0.001) and meconium aspiration (4 vs. 0%; P = 0.007) were found to be significantly increased in the meconium group.

Conclusion

Statistically significant increased incidence of chorioamnionitis and endomyometritis in women with MSAF in labor established in our study strongly supports the use of prophylactic antibiotics in these women to prevent immediate and long-term consequences.
Literatur
1.
Zurück zum Zitat James D, Steer P, Weiner CP. High risk pregnancy management options. 4th ed. Amsterdam: Elsevier; 2011. p. 1135–40. James D, Steer P, Weiner CP. High risk pregnancy management options. 4th ed. Amsterdam: Elsevier; 2011. p. 1135–40.
2.
Zurück zum Zitat Monen L, Hasaart TH, Kuppens SM. The aetiology of meconium-stained amniotic fluid: pathologic hypoxia or physiologic foetal ripening? (review). Early Hum Dev. 2014;90(7):325–8.CrossRefPubMed Monen L, Hasaart TH, Kuppens SM. The aetiology of meconium-stained amniotic fluid: pathologic hypoxia or physiologic foetal ripening? (review). Early Hum Dev. 2014;90(7):325–8.CrossRefPubMed
3.
Zurück zum Zitat Romero R, Yoon BH, Chaemsaithong P, et al. Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage? J Matern Fetal Neonatal Med. 2014;27(8):775–88.CrossRefPubMed Romero R, Yoon BH, Chaemsaithong P, et al. Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage? J Matern Fetal Neonatal Med. 2014;27(8):775–88.CrossRefPubMed
4.
Zurück zum Zitat Brabbing-Goldstein D, Nir D, Cohen D, et al. Preterm meconium-stained amniotic fluid is an ominous sign for the development of chorioamnionitis and for in utero cord compression. J Matern Fetal Neonatal Med. 2017;8:1–4. Brabbing-Goldstein D, Nir D, Cohen D, et al. Preterm meconium-stained amniotic fluid is an ominous sign for the development of chorioamnionitis and for in utero cord compression. J Matern Fetal Neonatal Med. 2017;8:1–4.
5.
Zurück zum Zitat Hiersch L, Krispin E, Aviram A, et al. Effect of meconium stained amniotic fluid on low risk pregnancies at term. Am J Perinatol. 2016;33(4):378–84.PubMed Hiersch L, Krispin E, Aviram A, et al. Effect of meconium stained amniotic fluid on low risk pregnancies at term. Am J Perinatol. 2016;33(4):378–84.PubMed
6.
Zurück zum Zitat Vain NE, Batton DG. Meconium “aspiration” (or respiratory distress associated with meconium-stained amniotic fluid?). Semin Fetal Neonatal Med. 2017;11:S1744-165X. Vain NE, Batton DG. Meconium “aspiration” (or respiratory distress associated with meconium-stained amniotic fluid?). Semin Fetal Neonatal Med. 2017;11:S1744-165X.
7.
Zurück zum Zitat Hiersch L, Krispin E, Linder N, et al. Meconium-stained amniotic fluid and neonatal morbidity in low-risk pregnancies at term: the effect of gestational age. Am J Perinatol. 2017;34(2):183–90.PubMed Hiersch L, Krispin E, Linder N, et al. Meconium-stained amniotic fluid and neonatal morbidity in low-risk pregnancies at term: the effect of gestational age. Am J Perinatol. 2017;34(2):183–90.PubMed
8.
Zurück zum Zitat Hiersch L, Krispin E, Aviram A, et al. Effect of meconium-stained amniotic fluid on perinatal complications in low-risk pregnancies at term. Am J Perinatol. 2016;33(4):378–84.PubMed Hiersch L, Krispin E, Aviram A, et al. Effect of meconium-stained amniotic fluid on perinatal complications in low-risk pregnancies at term. Am J Perinatol. 2016;33(4):378–84.PubMed
9.
Zurück zum Zitat Pariente G, Peles C, Perri ZH, et al. Meconium-stained amniotic fluid—risk factors and immediate perinatal outcomes among SGA infants. J Matern Fetal Neonatal Med. 2015;28(9):1064–7.CrossRefPubMed Pariente G, Peles C, Perri ZH, et al. Meconium-stained amniotic fluid—risk factors and immediate perinatal outcomes among SGA infants. J Matern Fetal Neonatal Med. 2015;28(9):1064–7.CrossRefPubMed
10.
Zurück zum Zitat Hiersch L, Melamed N, Rosen H, et al. New onset of meconium during labor versus primary meconium-stained amniotic fluid—is there a difference in pregnancy outcome? J Matern Fetal Neonatal Med. 2014;27(13):1361–7.CrossRefPubMed Hiersch L, Melamed N, Rosen H, et al. New onset of meconium during labor versus primary meconium-stained amniotic fluid—is there a difference in pregnancy outcome? J Matern Fetal Neonatal Med. 2014;27(13):1361–7.CrossRefPubMed
11.
Zurück zum Zitat Wu HC, Shen CM, Wu YY, et al. Subclinical histologic chorioamnionitis and related clinical and laboratory parameters in preterm. Pediatr Neonatol. 2009;50(5):217–21.CrossRefPubMed Wu HC, Shen CM, Wu YY, et al. Subclinical histologic chorioamnionitis and related clinical and laboratory parameters in preterm. Pediatr Neonatol. 2009;50(5):217–21.CrossRefPubMed
12.
Zurück zum Zitat Siriwachirachai T, Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Anibiotics for meconium stained amniotic fluid in labour preventing maternal and neonatal infections. Cochrane Database Syst Rev. 2010;8(12):1–19. Siriwachirachai T, Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Anibiotics for meconium stained amniotic fluid in labour preventing maternal and neonatal infections. Cochrane Database Syst Rev. 2010;8(12):1–19.
13.
Zurück zum Zitat Siriwachirachai T, Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Antibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infections. Cochrane Database Syst Rev. 2014;6(11):1–24. Siriwachirachai T, Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Antibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infections. Cochrane Database Syst Rev. 2014;6(11):1–24.
Metadaten
Titel
New Evidence to Support Antibiotic Prophylaxis in Meconium-Stained Amniotic Fluid in Low-Risk Women in Labor a Prospective Cohort Study
verfasst von
Kavitha Abraham
Elsy Thomas
Jessie Lionel
Publikationsdatum
01.09.2017
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 5/2018
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-017-1043-y

Weitere Artikel der Ausgabe 5/2018

The Journal of Obstetrics and Gynecology of India 5/2018 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.